Latest News About Emma.

Here are the latest updates I can share about EMMA right now.

• EMMA (Emmaus Life Sciences, ticker EMMA) has seen coverage around regulatory and financial updates in recent months, including FDA labeling developments and quarterly performance notes from 2024, with market coverage highlighting Endari prescriptions and supply-chain challenges. These sources discuss label updates for Endari and the company’s financial results, but there is no single, definitive “latest” event that supersedes all others in real time. Please note the information reflects the most recent items available in public summaries from those outlets as of mid-2025 to 2026.[1][6]

• In other EMMA-related news spaces, results vary by organization and industry. For example, aviation-focused EMMA Systems and Emma AI platforms appear in separate contexts, so be sure you’re tracking the correct EMMA entity for your needs (biopharma EMMA vs. aviation tech EMMA). If you’re looking for updates specifically on Emmaus Life Sciences, I can narrow to corporate press releases or financial filings.[3][7]

What I can do next

• Narrow to EMMA (Emmaus Life Sciences) only and pull the very latest press releases, regulatory actions, or earnings marks if you’d like.
• Filter to a specific date range (e.g., last 30 days) to give you the freshest items.
• If you meant a different EMMA (e.g., EMMA Systems in aviation or Emma AI platforms), tell me which one and I’ll pull up-to-date details for that entity.

Would you like me to focus on Emmaus Life Sciences (EMMA) and fetch the newest press releases and regulatory updates, or specify a different EMMA entity? I can also provide a concise timeline of notable events if that’s helpful.